Ardelyx
ARDX
#5264
Rank
A$2.18 B
Marketcap
A$9.00
Share price
1.01%
Change (1 day)
5.58%
Change (1 year)

Revenue for Ardelyx (ARDX)

Revenue in 2025 (TTM): A$0.62 Billion

According to Ardelyx's latest financial reports the company's current revenue (TTM ) is A$0.59 Billion. In 2024 the company made a revenue of A$0.53 Billion an increase over the revenue in the year 2023 that were of A$0.18 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ardelyx from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) A$0.62 B15.74%
2024 A$0.53 B193.61%
2023 A$0.18 B138.33%
2022 A$76.64 M450.33%
2021 A$13.92 M41.45%
2020 A$9.84 M30.54%
2019 A$7.54 M103.82%
2018 A$3.7 M-93.12%
2017 A$53.79 M
2016 N/A-100%
2015 A$32.98 M-14.65%
2014 A$38.64 M19.15%
2013 A$32.43 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
A$0.96 B 61.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$54.15 B 8,932.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$71.54 B 11,833.96%๐Ÿ‡ซ๐Ÿ‡ท France
Abbott Laboratories
ABT
A$66.00 B 10,909.36%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$87.51 B 14,496.19%๐Ÿ‡ฌ๐Ÿ‡ง UK